| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £500.19M | 7.43 | 16.51% | 0.02% | 16.42% | 33.07% | |
73 Outperform | £666.27M | 8.15 | 20.95% | 3.00% | 6.52% | 59.56% | |
69 Neutral | £46.90M | 4.30 | 10.87% | ― | 5.39% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
45 Neutral | £5.71M | -1.13 | -30.89% | ― | -6.07% | 50.59% | |
44 Neutral | £323.23K | -0.13 | ― | ― | ― | ― |